Supplementary Table S1 from Enhanced Antitumor Effects of Novel Intracellular Delivery of an Active Form of Menaquinone-4, Menahydroquinone-4, into Hepatocellular Carcinoma

Authors:
  • SSShuichi Setoguchi
    Shuichi Setoguchi
  • DWDaisuke Watase
    Daisuke Watase
  • KMKazuhisa Matsunaga
    Kazuhisa Matsunaga
  • MMMisa Matsubara
    Misa Matsubara
  • YKYohei Kubo
    Yohei Kubo
  • MKMariko Kusuda
    Mariko Kusuda
  • NNNami Nagata-Akaho
    Nami Nagata-Akaho
  • MEMunechika Enjoji
    Munechika Enjoji
  • MNManabu Nakashima
    Manabu Nakashima
  • MTMorishige Takeshita
    Morishige Takeshita
  • YKYoshiharu Karube
    Yoshiharu Karube
  • JTJiro Takata
    Jiro Takata

Abstract
Supplementary Table S1. Growth inhibition IC50 values of MK-4 and MKH-DMG against HCC cell lines after treatment with MK-4 or MKH-DMG.